Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

An adaptive design for updating the threshold value of a continuous biomarker

Spencer, Amy V., Harbron, Chris, Mander, Adrian ORCID: https://orcid.org/0000-0002-0742-9040, Wason, James and Peers, Ian 2016. An adaptive design for updating the threshold value of a continuous biomarker. Statistics in Medicine 35 (27) , p. 4909. 10.1002/sim.7042

[thumbnail of Spencer_et_al-2016-Statistics_in_Medicine.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (685kB)

Abstract

Potential predictive biomarkers are often measured on a continuous scale, but in practice, a threshold value to divide the patient population into biomarker ‘positive’ and ‘negative’ is desirable. Early phase clinical trials are increasingly using biomarkers for patient selection, but at this stage, it is likely that little will be known about the relationship between the biomarker and the treatment outcome. We describe a single‐arm trial design with adaptive enrichment, which can increase power to demonstrate efficacy within a patient subpopulation, the parameters of which are also estimated. Our design enables us to learn about the biomarker and optimally adjust the threshold during the study, using a combination of generalised linear modelling and Bayesian prediction. At the final analysis, a binomial exact test is carried out, allowing the hypothesis that ‘no population subset exists in which the novel treatment has a desirable response rate’ to be tested. Through extensive simulations, we are able to show increased power over fixed threshold methods in many situations without increasing the type‐I error rate. We also show that estimates of the threshold, which defines the population subset, are unbiased and often more precise than those from fixed threshold studies. We provide an example of the method applied (retrospectively) to publically available data from a study of the use of tamoxifen after mastectomy by the German Breast Study Group, where progesterone receptor is the biomarker of interest.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Centre for Trials Research (CNTRR)
Publisher: Wiley
ISSN: 0277-6715
Date of First Compliant Deposit: 12 June 2019
Date of Acceptance: 22 June 2016
Last Modified: 04 May 2023 19:36
URI: https://orca.cardiff.ac.uk/id/eprint/123284

Citation Data

Cited 9 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics